Thomas Seck

Thomas Seck

Head of Clinical Development Cardiometabolic Health

Role
Senior Vice President Head of Clinical Development Cardiometabolic Health at Eli Lilly and Company
Location
New York, NY, US
LinkedIn followers
500 followers

Experience

  1. Senior Vice President Head of Clinical Development Cardiometabolic Health

    Eli Lilly and Company

    Feb 2026 — Present

Education

  • Yale University

    Postdoctoral Fellowship, Cell Biology - Bone Metabolism

    2001 — 2002

  • Heidelberg University

    Residency and Fellowship Internal Medicine/Endocrinology

    1995 — 2000

  • Johannes Gutenberg University Mainz

    MD, Medicine

    1989 — 1995

  • Ruhr University Bochum

    Assistant Professor, Endocrinology

    2003 — 2006

Skills

  • Biotechnology
  • Diabetes
  • Clinical Monitoring
  • Vaccines
  • Ich-Gcp
  • CRO
  • Regulatory Affairs
  • Medical Writing
  • Oncology
  • Protocol
  • Clinical Trials
  • Metabolism
  • Clinical Development
  • Infectious Diseases
  • Pharmacovigilance
  • Biomarkers
  • Pharmaceutical Industry
  • Pharmacokinetics
  • Clinical Research
  • Clinical Pharmacology
  • Regulatory Submissions
  • Drug Discovery
  • Edc
  • Therapeutic Areas
  • Pharmacology
  • Ctms
  • Drug Development
  • Medical Affairs
  • Gcp
  • Translational Medicine
  • Endocrinology
  • Clinical Study Design
  • Immunology

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Thomas Seck — Senior Vice President Head of Clinical Development Cardiometabolic Health at Eli Lilly and Company in New York, NY, US | Unifers